Skip to main content

Table 3 Resistance status to rifampicin by GeneXpert MTB/RIF on paired spot specimens and morning specimens

From: Spot specimen testing with GeneXpert MTB/RIF results compared to morning specimen in a programmatic setting in Cotonou, Benin

Morning specimen

Spot specimen

Resistant

Susceptible

Total

Resistant

2

2*

4

Susceptible

0

148

148

Total

2

150

152

  1. *Confirmed as RIF-susceptible by repeat GeneXpert MTB/RIF and phenotypic drug-susceptibility testing